Literature DB >> 22288516

Beliefs about medications as a predictor of treatment adherence in women with urinary incontinence.

Emily K Saks1, Douglas J Wiebe, Lori A Cory, Mary D Sammel, Lily A Arya.   

Abstract

OBJECTIVE: To investigate the association between beliefs about medications and primary adherence in women prescribed anticholinergic medications for urgency urinary incontinence (UUI).
METHODS: We enrolled 160 women with UUI who were prescribed anticholinergic medications between 2009 and 2010. Validated questionnaires were administered to measure the diagnosis of UUI, its impact on quality of life, and beliefs about medications. Primary adherence, filling of a prescription within 30 days, was measured through pharmacy records. The association between healthcare beliefs and primary adherence was measured using multivariable analysis.
RESULTS: The incidence of primary adherence to anticholinergic medication was 73%. Of the women, 5% reported belief in the general harm of medicines, 31% reported belief in the general overuse of medicines, and 90% reported belief in the general benefit of medicines. Responses to the Beliefs about Medicines Questionnaire (BMQ) had good internal consistency in women with UUI (Cronbach's alpha 0.59-0.75). On univariable analysis, belief in the general overuse of medicines (odds ratio [OR] 0.48, 95% confidence interval [CI] 0.23-0.99) and belief in the general harm of medicines (OR 0.11, 95% CI 0.02-0.57) were significant negative predictors of primary adherence to anticholinergic medications. A significant relationship between the impact of urinary symptoms on quality of life and primary adherence was not noted (OR 1.02, 95% CI 0.86-1.22). On multivariable analysis, belief in the general overuse of medicines remained a significant negative predictor of primary adherence (OR 0.35, 95% CI 0.16-0.79).
CONCLUSIONS: Women with UUI who believe that medicines in general are overused are less likely to fill their prescriptions for anticholinergic medications.

Entities:  

Mesh:

Year:  2012        PMID: 22288516     DOI: 10.1089/jwh.2011.2952

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN: 1540-9996            Impact factor:   2.681


  6 in total

1.  Adverse Events Associated with Nonsurgical Treatments for Urinary Incontinence in Women: a Systematic Review.

Authors:  Ethan M Balk; Gaelen P Adam; Katherine Corsi; Amanda Mogul; Thomas A Trikalinos; Peter C Jeppson
Journal:  J Gen Intern Med       Date:  2019-05-06       Impact factor: 5.128

2.  Use, attitudes and knowledge of medications among pregnant women: A Saudi study.

Authors:  Noha M Zaki; Ahmed A Albarraq
Journal:  Saudi Pharm J       Date:  2013-10-23       Impact factor: 4.330

3.  Associations between generic substitution and patients' attitudes, beliefs and experiences.

Authors:  Jette Rathe; Pia Larsen; Morten Andersen; Maja Paulsen; Dorte Jarbøl; Janus Thomsen; Jens Soendergaard
Journal:  Eur J Clin Pharmacol       Date:  2013-06-14       Impact factor: 2.953

Review 4.  Nonbiologic factors that impact management in women with urinary incontinence: review of the literature and findings from a National Institute of Diabetes and Digestive and Kidney Diseases workshop.

Authors:  Jenna M Norton; Jennifer L Dodson; Diane K Newman; Rebecca G Rogers; Andrea D Fairman; Helen L Coons; Robert A Star; Tamara G Bavendam
Journal:  Int Urogynecol J       Date:  2017-07-03       Impact factor: 2.894

Review 5.  Understanding patients' adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the Necessity-Concerns Framework.

Authors:  Rob Horne; Sarah C E Chapman; Rhian Parham; Nick Freemantle; Alastair Forbes; Vanessa Cooper
Journal:  PLoS One       Date:  2013-12-02       Impact factor: 3.240

6.  Beliefs About Medicines and Self-reported Adherence Among Patients with Chronic Illness: A Study in Palestine.

Authors:  Raniah Majed Jamous; Waleed Mohamad Sweileh; Adham Saed El-Deen Abu Taha; Sa'ed Husni Zyoud
Journal:  J Family Med Prim Care       Date:  2014-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.